
Overview
Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits.
Dr. Cherry is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.
Dr. Cherry is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 13 clinical trials. Dr. Cherry is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 Madison Avenue, Carol G Simon Cancer Center 2nd Floor Null, Morristown, NJ 07960
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
13 Clinical Trials
Carol G. Simon Cancer Center
Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Farber is board certified in American Board Of Internal Medicine. Dr. Farber is currently accepting new patients.
Atlantic Hematology Oncology
"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer. Dr. Alistar is board certified in American Board Of Internal Medicine. Dr. Alistar is currently accepting new patients.
Garden State Urology
The relationship between patient and physician is a partnership and the best medicine is practiced as part of a team-based approach with patients, their families and their other physicians. As an experienced fellowship-trained, minimally-invasive urologic oncologic surgeon, my role as your advisor is to provide the most effective medical and surgical techniques for the management of prostate, bladder, kidney, testicular and adrenal cancers. This not only takes into account the disease process, but importantly recognizes the effect on quality-of-life on both patients and caregivers during and following treatment. Education and communication are the hallmarks of ensuring that we are part of a successful team together. Dr. Prasad is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Bladder Cancer, Prostate Cancer, Ureteroscopy, and Bladder Reconstruction. Dr. Prasad is board certified in American Board Of Urology. Dr. Prasad is currently accepting new patients.
Atlantic Women's Cancer Associates
Nana Tchabo, MD, FACOG Dr. Nana Tchabo is dual board certified in gynecology-oncology and obstetrics and gynecology, with fellowship training in minimally invasive gynecologic surgery and robotic procedures. A native of Baltimore, MD, Dr. Tchabo is a gynecologic oncologist at Atlantic Health System’s Morristown and Overlook Medical Centers Women’s Cancer Center, part of the Atlantic Medical Group. After graduating from Brown University in 1996 with a bachelor’s degree in neuroscience and a minor in women’s health, Dr. Tchabo attended Brown University School of Medicine for her medical degree, where she was cited for academic excellence. Dr. Tchabo completed her residency in obstetrics and gynecology at Georgetown University in 2004 and pursued additional research training at the National Cancer Institute of the National Institutes of Health in Bethesda, MD, and gynecologic oncology fellowship training at Roswell Park Cancer Institute in Buffalo, NY. Committed to cancer prevention and survivorship, Dr. Tchabo is a principal investigator on many of the gynecologic cancer clinical research trials available at the Carol G. Simon Cancer Center. She also serves as associate residency director for Gynecology at Overlook Medical Center. Dr. Tchabo is an assistant clinical professor at the Sidney Kimmel Medical College of Thomas Jefferson University and is a former assistant clinical professor at Mount Sinai School of Medicine’s department of Obstetrics, Gynecology and Reproductive Science. Dr. Tchabo is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, Ureteroscopy, and Salpingo-Oophorectomy. Dr. Tchabo is board certified in American Board Of Obstetrics And Gynecology. Dr. Tchabo is currently accepting new patients.
Carol G Simon Cancer Center
Ahmed Galal is a Hematologist and an Oncologist practicing medicine in Morristown, New Jersey. Dr. Galal is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Galal is currently accepting new patients.
Garden State Urology
It’s important to me to connect with my patients on a personal level, which helps me better understand their problems and concerns. I’m genuinely interested in them and their families and improving their quality of life, and I encourage everyone in the practice to treat patients with that same level of compassion. My patients perceive me as an experienced, compassionate urologic surgeon they can rely on. I enjoy treating the entire range of urologic disorders, with a special interest in oncology and kidney problems. Dr. Taylor is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Taylor is board certified in American Board Of Urology. Dr. Taylor is currently accepting new patients.
Frequently Asked Questions about Dr. Mohamad A. Cherry
How do I make an appointment with Dr. Mohamad A. Cherry?
You can book an appointment with Dr. Mohamad A. Cherry by calling their office at 973-971-7960. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mohamad A. Cherry a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mohamad A. Cherry is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mohamad A. Cherry specialize in?
While Dr. Mohamad A. Cherry is a Hematology, they have specific expertise in Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, and Acute Myeloblastic Leukemia without Maturation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Mohamad A. Cherry participate in research or clinical trials?
Yes. Dr. Mohamad A. Cherry has published 36 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Mohamad A. Cherry's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mohamad A. Cherry accept my insurance?
Dr. Mohamad A. Cherry accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 973-971-7960 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia with MaturationDr. Cherry isDistinguished. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Cherry isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Cherry isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Cherry isDistinguished. Learn about Alveolar Soft Part Sarcoma.
- Bone TumorDr. Cherry isDistinguished. Learn about Bone Tumor.
- Chronic Lymphocytic Leukemia (CLL)Dr. Cherry isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- GanglioneuroblastomaDr. Cherry isDistinguished. Learn about Ganglioneuroblastoma.
- Large-Cell Immunoblastic LymphomaDr. Cherry isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Midline Lethal GranulomaDr. Cherry isDistinguished. Learn about Midline Lethal Granuloma.
- Myelodysplastic Syndrome (MDS)Dr. Cherry isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaDr. Cherry isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Rhabdoid TumorDr. Cherry isDistinguished. Learn about Rhabdoid Tumor.
- Rhabdoid Tumor Predisposition SyndromeDr. Cherry isDistinguished. Learn about Rhabdoid Tumor Predisposition Syndrome.
- Synovial SarcomaDr. Cherry isDistinguished. Learn about Synovial Sarcoma.
- Advanced
- Acute Myelomonocytic LeukemiaDr. Cherry isAdvanced. Learn about Acute Myelomonocytic Leukemia.
- B-Cell LymphomaDr. Cherry isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Cherry isAdvanced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid LeukemiaDr. Cherry isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Cherry isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Familial NeutropeniaDr. Cherry isAdvanced. Learn about Chronic Familial Neutropenia.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Epithelioid SarcomaDr. Cherry isAdvanced. Learn about Epithelioid Sarcoma.
- Essential ThrombocythemiaDr. Cherry isAdvanced. Learn about Essential Thrombocythemia.
- Febrile NeutropeniaDr. Cherry isAdvanced. Learn about Febrile Neutropenia.
- FibrosarcomaDr. Cherry isAdvanced. Learn about Fibrosarcoma.
- Follicular LymphomaDr. Cherry isAdvanced. Learn about Follicular Lymphoma.
- GanglioneuromaDr. Cherry isAdvanced. Learn about Ganglioneuroma.
- Gastric LymphomaDr. Cherry isAdvanced. Learn about Gastric Lymphoma.
- Hodgkin LymphomaDr. Cherry isAdvanced. Learn about Hodgkin Lymphoma.
- LeukemiaDr. Cherry isAdvanced. Learn about Leukemia.
- LiposarcomaDr. Cherry isAdvanced. Learn about Liposarcoma.
- Marginal Zone Lymphoma (MZL)Dr. Cherry isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Mediastinal TumorDr. Cherry isAdvanced. Learn about Mediastinal Tumor.
- MesenchymomaDr. Cherry isAdvanced. Learn about Mesenchymoma.
- Myxoid LiposarcomaDr. Cherry isAdvanced. Learn about Myxoid Liposarcoma.
- PlasmacytomaDr. Cherry isAdvanced. Learn about Plasmacytoma.
- Polycythemia VeraDr. Cherry isAdvanced. Learn about Polycythemia Vera.
- RhabdomyosarcomaDr. Cherry isAdvanced. Learn about Rhabdomyosarcoma.
- Rhabdomyosarcoma EmbryonalDr. Cherry isAdvanced. Learn about Rhabdomyosarcoma Embryonal.
- Richter SyndromeDr. Cherry isAdvanced. Learn about Richter Syndrome.
- Small Lymphocytic Lymphoma (SLL)Dr. Cherry isAdvanced. Learn about Small Lymphocytic Lymphoma (SLL).
- T-Cell LymphomaDr. Cherry isAdvanced. Learn about T-Cell Lymphoma.
- Undifferentiated Pleomorphic Sarcoma
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Cherry isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Megakaryoblastic LeukemiaDr. Cherry isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Promyelocytic LeukemiaDr. Cherry isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult T-Cell LeukemiaDr. Cherry isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Cherry isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Cherry isExperienced. Learn about Anemia.
- Aplastic AnemiaDr. Cherry isExperienced. Learn about Aplastic Anemia.
- Blood ClotsDr. Cherry isExperienced. Learn about Blood Clots.
- ChondrosarcomaDr. Cherry isExperienced. Learn about Chondrosarcoma.
- Chronic Myelogenous Leukemia (CML)Dr. Cherry isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic Myelomonocytic Leukemia (CMML)Dr. Cherry isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Chronic T-Cell Leukemia (CTCL)Dr. Cherry isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Classical Hodgkin LymphomaDr. Cherry isExperienced. Learn about Classical Hodgkin Lymphoma.
- Congenital Hemolytic AnemiaDr. Cherry isExperienced. Learn about Congenital Hemolytic Anemia.
- Deep Vein ThrombosisDr. Cherry isExperienced. Learn about Deep Vein Thrombosis.
- Ewing SarcomaDr. Cherry isExperienced. Learn about Ewing Sarcoma.
- Familial Pancreatic CancerDr. Cherry isExperienced. Learn about Familial Pancreatic Cancer.
- GangliogliomaDr. Cherry isExperienced. Learn about Ganglioglioma.
- Hemolytic AnemiaDr. Cherry isExperienced. Learn about Hemolytic Anemia.
- Hemolytic CrisisDr. Cherry isExperienced. Learn about Hemolytic Crisis.
- Hereditary SpherocytosisDr. Cherry isExperienced. Learn about Hereditary Spherocytosis.
- Idiopathic NeutropeniaDr. Cherry isExperienced. Learn about Idiopathic Neutropenia.
- Legius SyndromeDr. Cherry isExperienced. Learn about Legius Syndrome.
- LeukocytosisDr. Cherry isExperienced. Learn about Leukocytosis.
- Lymphofollicular HyperplasiaDr. Cherry isExperienced. Learn about Lymphofollicular Hyperplasia.
- Mantle Cell Lymphoma (MCL)Dr. Cherry isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Cherry isExperienced. Learn about Multiple Myeloma.
- MyelofibrosisDr. Cherry isExperienced. Learn about Myelofibrosis.
- NeurofibromatosisDr. Cherry isExperienced. Learn about Neurofibromatosis.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- OsteosarcomaDr. Cherry isExperienced. Learn about Osteosarcoma.
- Pancreatic CancerDr. Cherry isExperienced. Learn about Pancreatic Cancer.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Primary Lymphoma of the BrainDr. Cherry isExperienced. Learn about Primary Lymphoma of the Brain.
- Primary Mediastinal B-Cell Lymphoma (PMBCL)
- Pulmonary EmbolismDr. Cherry isExperienced. Learn about Pulmonary Embolism.
- Pure Red Cell AplasiaDr. Cherry isExperienced. Learn about Pure Red Cell Aplasia.
- RASopathiesDr. Cherry isExperienced. Learn about RASopathies.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Schnitzler SyndromeDr. Cherry isExperienced. Learn about Schnitzler Syndrome.
- Severe Congenital NeutropeniaDr. Cherry isExperienced. Learn about Severe Congenital Neutropenia.
- Shwartzman PhenomenonDr. Cherry isExperienced. Learn about Shwartzman Phenomenon.
- Smoldering Multiple MyelomaDr. Cherry isExperienced. Learn about Smoldering Multiple Myeloma.
- SplenomegalyDr. Cherry isExperienced. Learn about Splenomegaly.
- ThrombocytopeniaDr. Cherry isExperienced. Learn about Thrombocytopenia.
- Transient Erythroblastopenia of Childhood
- Venous Thromboembolism (VTE)Dr. Cherry isExperienced. Learn about Venous Thromboembolism (VTE).
- Waldenstrom MacroglobulinemiaDr. Cherry isExperienced. Learn about Waldenstrom Macroglobulinemia.




